TY  - JOUR
AU  - Fuentes-Fayos, Antonio C
AU  - Vazquez-Borrego, Mari C
AU  - Jimenez-Vacas, Juan M
AU  - Bejarano, Leire
AU  - Pedraza-Arevalo, Sergio
AU  - L-Lopez, Fernando
AU  - Blanco-Acevedo, Cristobal
AU  - Sanchez-Sanchez, Rafael
AU  - Reyes, Oscar
AU  - Ventura, Sebastian
AU  - Solivera, Juan
AU  - Breunig, Joshua J
AU  - Blasco, Maria A
AU  - Gahete, Manuel D
AU  - Castaño, Justo P
AU  - Luque, Raul M
PY  - 2020
DO  - 10.1093/brain/awaa273
UR  - http://hdl.handle.net/10668/16534
T2  - Brain : a journal of neurology
AB  - Glioblastomas remain the deadliest brain tumour, with a dismal ∼12-16-month survival from diagnosis. Therefore, identification of new diagnostic, prognostic and therapeutic tools to tackle glioblastomas is urgently needed. Emerging evidence indicates...
LA  - en
PB  - Oxford University Press
KW  - PDGFRB pathway
KW  - SRSF3
KW  - Antitumour therapy
KW  - Glioblastoma
KW  - Splicing machinery
KW  - Alternative splicing
KW  - Apoptosis
KW  - Biomarkers, tumor
KW  - Brain neoplasms
KW  - Cell movement
KW  - Cell proliferation
KW  - Gene expression regulation, neoplastic
KW  - Gene silencing
KW  - Glioblastoma
KW  - Humans
KW  - Neoplasm invasiveness
KW  - Receptor, platelet-derived growth factor beta
KW  - Serine-arginine splicing factors
KW  - Signal transduction
KW  - Survival analysis
KW  - Xenograft model antitumor assays
TI  - Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.
TY  - research article
VL  - 143
ER  -